Micaela Gal

1.6k total citations
40 papers, 1.0k citations indexed

About

Micaela Gal is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Micaela Gal has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Infectious Diseases and 10 papers in Clinical Biochemistry. Recurrent topics in Micaela Gal's work include Bacterial Identification and Susceptibility Testing (10 papers), Antibiotic Use and Resistance (7 papers) and Urinary Tract Infections Management (7 papers). Micaela Gal is often cited by papers focused on Bacterial Identification and Susceptibility Testing (10 papers), Antibiotic Use and Resistance (7 papers) and Urinary Tract Infections Management (7 papers). Micaela Gal collaborates with scholars based in United Kingdom, Australia and Spain. Micaela Gal's co-authors include Christopher Butler, Nick Francis, Kerenza Hood, John Brazier, Mandy Wootton, Emma Thomas‐Jones, Paul B. Rainey, Andrew J. Spiers, Ruth C. Massey and Gail M. Preston and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Micaela Gal

35 papers receiving 974 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Micaela Gal United Kingdom 19 304 248 184 171 147 40 1.0k
Patricia Pavèse France 24 644 2.1× 468 1.9× 220 1.2× 209 1.2× 200 1.4× 113 1.6k
Ioanna Korbila Greece 14 503 1.7× 283 1.1× 99 0.5× 231 1.4× 80 0.5× 23 1.2k
Debra L. Palazzi United States 20 392 1.3× 524 2.1× 182 1.0× 399 2.3× 84 0.6× 61 1.3k
Rajeshwari Nair United States 17 329 1.1× 508 2.0× 279 1.5× 136 0.8× 198 1.3× 56 1.3k
Claude Afif Lebanon 17 556 1.8× 466 1.9× 97 0.5× 103 0.6× 107 0.7× 39 1.2k
Dag Berild Norway 19 348 1.1× 166 0.7× 88 0.5× 138 0.8× 308 2.1× 83 961
Louise‐Marie Dembry United States 17 383 1.3× 383 1.5× 111 0.6× 409 2.4× 54 0.4× 35 982
C. Ruef Switzerland 19 600 2.0× 491 2.0× 246 1.3× 250 1.5× 238 1.6× 49 1.6k
George H. Karam United States 13 567 1.9× 364 1.5× 139 0.8× 63 0.4× 337 2.3× 24 1.4k
Dong Sik Jung South Korea 19 512 1.7× 367 1.5× 111 0.6× 66 0.4× 183 1.2× 41 1.1k

Countries citing papers authored by Micaela Gal

Since Specialization
Citations

This map shows the geographic impact of Micaela Gal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micaela Gal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micaela Gal more than expected).

Fields of papers citing papers by Micaela Gal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Micaela Gal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micaela Gal. The network helps show where Micaela Gal may publish in the future.

Co-authorship network of co-authors of Micaela Gal

This figure shows the co-authorship network connecting the top 25 collaborators of Micaela Gal. A scholar is included among the top collaborators of Micaela Gal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Micaela Gal. Micaela Gal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, Alison, Ruth Lewis, Micaela Gal, et al.. (2024). Informing evidence-based policy during the COVID-19 pandemic and recovery period: learning from a national evidence centre. Global Health Research and Policy. 9(1). 18–18. 3 indexed citations
3.
Edwards, Deborah, Judith Carrier, Elizabeth Gillen, et al.. (2022). A rapid review of strategies to support learning and wellbeing among 16-19 year old learners who have experienced significant disruption in their education as a result of the COVID-19 pandemic. ORCA Online Research @Cardiff (Cardiff University). 1 indexed citations
4.
Phillips, Rhiannon, David Gillespie, Janine Bates, et al.. (2020). C-reactive protein-guided antibiotic prescribing for COPD exacerbations: a qualitative evaluation. British Journal of General Practice. 70(696). e505–e513. 8 indexed citations
5.
Gregory, Clive, Micaela Gal, David Gillespie, et al.. (2020). The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study. BJGP Open. 4(2). bjgpopen20X101006–bjgpopen20X101006. 2 indexed citations
6.
Gadalla, Amal, Ida M. Friberg, Ann Kift‐Morgan, et al.. (2019). Identification of clinical and urine biomarkers for uncomplicated urinary tract infection using machine learning algorithms. Scientific Reports. 9(1). 19694–19694. 52 indexed citations
7.
Gobat, Nina, Christopher Butler, Jill Mollison, et al.. (2019). What the public think about participation in medical research during an influenza pandemic: an international cross-sectional survey. Public Health. 177. 80–94. 23 indexed citations
8.
Francis, Nick, Rebecca Cannings‐John, Cherry-Ann Waldron, et al.. (2018). Oral steroids for resolution of otitis media with effusion in children (OSTRICH): a double-blinded, placebo-controlled randomised trial. The Lancet. 392(10147). 557–568. 23 indexed citations
9.
Butler, Christopher, Nick Francis, Emma Thomas‐Jones, et al.. (2018). Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness. British Journal of General Practice. 68(669). e268–e278. 33 indexed citations
10.
Gobat, Nina, Micaela Gal, Christopher Butler, et al.. (2017). Talking to the people that really matter about their participation in pandemic clinical research: A qualitative study in four European countries. Health Expectations. 21(1). 387–395. 24 indexed citations
11.
Gobat, Nina, Micaela Gal, Nick Francis, et al.. (2015). Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi/pandemic research preparedness. Trials. 16(1). 591–591. 26 indexed citations
12.
Bongard, Emily, Jens Kjølseth Møller, Micaela Gal, et al.. (2015). Analytic laboratory performance of a point of care urine culture kit for diagnosis and antibiotic susceptibility testing. European Journal of Clinical Microbiology & Infectious Diseases. 34(10). 2111–2119. 14 indexed citations
14.
Sóki, József, Micaela Gal, John Brazier, et al.. (2005). Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains. Journal of Antimicrobial Chemotherapy. 57(2). 212–220. 60 indexed citations
16.
Gal, Micaela, et al.. (2005). Subtyping of Clostridium difficile polymerase chain reaction (PCR) ribotype 001 by repetitive extragenic palindromic PCR genomic fingerprinting. Journal of Hospital Infection. 60(1). 56–60. 16 indexed citations
17.
Brazier, J S, Micaela Gal, Val Hall, & Trefor Morris. (2004). Epidémie d’infections à Clostridium histolyticum chez les utilisateurs de drogues injectables en Angleterre et en Ecosse. Eurosurveillance. 9(9). 1–2. 4 indexed citations
19.
Gal, Micaela. (2004). Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-resistant mutants. Journal of Antimicrobial Chemotherapy. 54(1). 109–116. 96 indexed citations
20.
Gal, Micaela, Gail M. Preston, Ruth C. Massey, Andrew J. Spiers, & Paul B. Rainey. (2003). Genes encoding a cellulosic polymer contribute toward the ecological success of Pseudomonas fluorescens SBW25 on plant surfaces. Molecular Ecology. 12(11). 3109–3121. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026